Kiora Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Property and Equipment

Property and Equipment

9 Months Ended

Sep. 30, 2021

Property and Equipment

Property and Equipment

3. Property and Equipment

Property and equipment at September 30, 2021 and December 31, 2020 consists of the following:


	Estimated Useful Life	September 30, 2021
	(Years)	(unaudited)		December 31, 2020
Laboratory Equipment	3	$	88,400	$	82,653
Office Equipment	3		3,693		3,888
Office Furniture	5		72,549		14,430
Leasehold Improvements	2		22,569		22,569
Total Property and Equipment, Gross			187,211		123,540
Less Accumulated Depreciation			108,378		92,974
Total Property and Equipment, Net		$	78,833	$	30,566

Depreciation expense was $4,807 and $2,388 for the three months ended September 30, 2021 and 2020, respectively, and $15,510 and $5,593 for the nine months ended September 30, 2021 and 2020, respectively.